Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating umbilical cord–derived mesenchymal stem cell therapy for ischemic cardiomyopathy, sponsored by Hebei Medical University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• Umbilical Cord Derived Mesenchymal Stem Cells Therapy (umbilical cord-derived mesenchymal stem cell therapy)

Snippet

Sponsor: Hebei Medical University | Conditions: Ischemic Cardiomyopathy | Phase 1 | Status: UNKNOWN